Oramed Pharmaceuticals Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oramed Pharmaceuticals Inc. on November 29, 2007. The company is incorporated in Nevada with principal executive offices in Jerusalem, Israel. The report addresses corporate governance updates rather than operational or financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance data.
Material Changes
The material change reported is the amendment of the company's Code of Ethics. On November 29, 2007, the Board of Directors passed a resolution to revoke the Code of Ethics adopted on October 6, 2004, and replace it with a new Code of Ethics.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the procedural update regarding the Code of Ethics.
Key Facts for Investor Verification
- The company replaced its 2004 Code of Ethics with a new version effective November 29, 2007.
- The new Code of Ethics is attached as Exhibit 14.1 to this filing.
- No financial results or operational updates are included in this specific report.